Silence Therapeutics (Nasdaq:SLN) develops and delivers short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical needs. Formed in 1994 as a publicly traded drug research and development company, Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters in Hammersmith, London.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:foundingYear |
|
| dbo:industry | |
| dbo:numberOfEmployees |
|
| dbo:thumbnail | |
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink | |
| dbp:foundation |
|
| dbp:homepage | |
| dbp:hqLocation |
|
| dbp:industry | |
| dbp:logo |
|
| dbp:name |
|
| dbp:numEmployees |
|
| dbp:type |
|
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| gold:hypernym | |
| rdf:type |
|
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| skos:closeMatch | |
| prov:wasDerivedFrom | |
| foaf:depiction | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |
